WANA (Dec 15) – An Iranian knowledge-based company has developed an innovative device called the Cancer Diagnostic Probe (CDP), enabling non-invasive detection of breast cancer.

 

According to the company’s project development manager, the CDP device boasts a detection accuracy of over 93%, allowing surgeons to identify cancerous cells during breast cancer surgeries and prevent the retention of cancerous margins in the body.

 

Mohammad Moeini highlighted that the use of this device reduces cancerous margins left in the body by approximately 30%. “The CDP offers a highly effective and non-invasive approach to breast cancer detection,” he stated.

 

Moeini also noted the device’s ability to evaluate previously undetected tumors, emphasizing its significant role in early disease diagnosis. The research team’s achievements include publications in prestigious international journals and securing five U.S. patents for their innovations.

 

Iran’s Innovative Wound Dressing Replaces Radiotherapy in Skin Cancer Treatment

WANA (Nov 09) – An Iranian team of researchers from Royan Biotechnology Institute in Isfahan has developed an innovative wound dressing that could eliminate the need for radiotherapy in skin cancer patients after tumor removal surgery.   Typically, cancer cells left in the wound area post-surgery increase the risk of recurrence, and radiotherapy is used […]

Read More...

 

The announcement was made during the 12th Iran-Made Exhibition for Advanced Laboratory Equipment and Testing, which commenced on Friday, December 13, at Tehran’s International Exhibition Center and concludes tomorrow.

 

This year’s event showcases over 10,085 products from 278 knowledge-based companies. On the first day, the President unveiled five selected innovations.

 

The exhibition’s primary focus this year is on advanced testing and diagnostic equipment to expand industrial applications and promote export markets for Iranian firms.